Indapamide Related Published Studies
Well-designed clinical trials related to Indapamide
Large volume injection of 1-octanol as sample diluent in reversed phase liquid chromatography: application in bioanalysis for assaying of indapamide in whole blood. [2011.04.05]
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. [2010.12]
Management of high blood pressure in type 2 diabetes: perindopril/indapamide fixed-dose combination and the ADVANCE trial [corrected]. [2010.07]
Combination therapy with angiotensin-converting enzyme inhibitors and indapamide impairs glucose tolerance in Chinese hypertensive patients. [2010.04]
Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension. [2009.12]
Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. [2009.05]
Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. [2009.05]
Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. [2008.12.15]
Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCE. [2008.06]
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. [2007.09.08]
Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. [2007.01]
Indapamide decreases plasma adiponectin concentration in patients with essential hypertension. [2007]
Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy. [2007]
Simple, sensitive and rapid LC-MS method for the quantitation of indapamide in human plasma--application to pharmacokinetic studies. [2006.09.14]
Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. [2006.01]
Rapid and sensitive determination of indapamide in human blood by liquid chromatography with electrospray ionization mass spectrometric detection: application to a bioequivalence study. [2005.11]
Evaluation of long-term efficacy and acceptability of indapamide SR in elderly hypertensive patients. [2005.01]
Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. [2004.12]
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. [2004.08]
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. [2004.08]
Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study. [2004.08]
Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry. [2004.05]
Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters. [2004.03]
Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. [2004.03]
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. [2004.01.07]
Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy. [2003.09]
Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes. [2003.08]
[Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment] [2003.07]
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. [2003.05.12]
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. [2003.05]
Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial. [2003.03]
Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study. [2003.02]
[Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study] [2002.09]
Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design. [2002.09]
Gender influence on the dose-ranging of a low-dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure. [2002.08]
Comparison of indapamide and low-dose hydrochlorothiazide monotherapy in black patients with mild to moderate hypertension. [2002.07]
Fixed combinations of delapril plus indapamide vs fosinopril plus hydrochlorothiazide in mild to moderate essential hypertension. [2002.05]
Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension. [2001.11]
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination. [2001.11]
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. [2001.10]
Antihypertensive efficacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension. [2001.05]
A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study. [2001.02]
Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. [2000.10]
Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison. [2000.03]
Pharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteers. [2000.03]
Fixed low-dose combination therapy in hypertension--a dose response study of perindopril and indapamide. [2000.03]
Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised controlled study. [2000.01]
Efficacy and safety of an oral fixed low-dose perindopril 2 MG/indapamide 0.625 MG combination: a randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension. [1999.10]
[Study on the antidiuretic efficacy and mechanism of indapamide in central diabetes insipidus] [1999]
Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group. [1998.11]
Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies. [1998.10]
Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension. [1997.04]
[Treatment of hypertension with indapamide 1.5 mg sustained-release form: synthesis of results] [1996.09]
Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria. [1996.08]
Indapamide is as effective as captopril in the control of microalbuminuria in diabetes. [1996.03]
Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria. [1996.02.22]
Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. [1996.02.22]
Indapamide regresses, but transdermal clonidine does not regress, left ventricular hypertrophy in hypertensive diabetic patients. [1996.02.22]
An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. [1995.12]
[Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study] [1995.08]
Conversion from 2.5 mg to 1.25 mg indapamide in patients with mild to moderate hypertension. [1995.07]
Efficacious response with lower dose indapamide therapy in the treatment of elderly patients with mild to moderate hypertension. [1995.01]
Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension. [1995]
Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. [1993]
Regression of microalbuminuria: results of a controlled study, indapamide versus captopril. [1993]
Indapamide reduces hypertensive left ventricular hypertrophy: an international multicenter study. [1993]
A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. [1991.08]
Comparison of indapamide and hydrochlorothiazide plus amiloride as a third drug in the treatment of arterial hypertension. [1989.04]
Effect of indapamide on serum and red cell cations, with and without magnesium supplementation, in subjects with mild hypertension. [1988.09.17]
Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide. [1988.01.29]
Comparative study on the antihypertensive efficacy of torasemide and indapamide in patients with essential hypertension. [1988.01]
Well-designed clinical trials possibly related to Indapamide
Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small,
randomized, double-blind, placebo-controlled, counterbalanced, crossover trial
assessing daily pain levels. [2013]
Long-term effects of doxazosin, finasteride, and combination therapy on quality
of life in men with benign prostatic hyperplasia. [2013]
Targeted anti-inflammatory systemic therapy for restenosis: The Biorest Liposomal
Alendronate with Stenting sTudy (BLAST)-a double blind, randomized clinical
trial. [2013]
A Multicentre Randomised Trial of Atorvastatin Therapy in Intensive Care Patients
with Severe Sepsis. [2013]
Sodium hyaluronate for the treatment of chronic shoulder pain associated with
glenohumeral osteoarthritis: a multicenter, randomized, double-blind,
placebo-controlled trial. [2013]
Effect of dietary myo-inositol supplementation in pregnancy on the incidence of
maternal gestational diabetes mellitus and fetal outcomes: a randomized
controlled trial. [2013]
Effect of vitamin D supplementation on progression of knee pain and cartilage
volume loss in patients with symptomatic osteoarthritis: a randomized controlled
trial. [2013]
Effect of valsartan on systemic right ventricular function: a double-blind,
randomized, placebo-controlled pilot trial. [2013]
Assessment of cognitive impairments and seizure characteristics in
electroconvulsive therapy with and without sodium valproate in manic patients. [2013]
Zinc and copper supplementation are not cost-effective interventions in the
treatment of acute diarrhea. [2013]
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D
conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster
randomised trial. [2013]
Efficacy and safety of everolimus for subependymal giant cell astrocytomas
associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised,
placebo-controlled phase 3 trial. [2013]
Randomized clinical trial of goal-directed fluid therapy within an enhanced
recovery protocol for elective colectomy. [2013]
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter
double-blind, randomized controlled trial. [2013]
Periarticular infiltration of 0.25% bupivacaine on top of femoral nerve block and
intrathecal morphine improves quality of pain control after total knee
arthroplasty: a randomized double-blind placebo controlled clinical trial. [2012]
Hyperbaric side effects in a traumatic brain injury randomized clinical trial. [2012]
Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural
palmitate) in the treatment of mild/moderate childhood atopic dermatitis
associated with pityriasis alba. A double-blind, placebo-controlled clinical
trial. [2012]
Randomized, double-blind, parallel-controlled clinical trial on correspondence of
prescriptions and traditional Chinese medicine syndrome of ischemic stroke. [2012]
[Meta-analysis of Dengzhanxixin injection treatment for unstable angina
pectoris]. [Article in Chinese] [2012]
Phase II trial of methotrexate in myasthenia gravis. [2012]
Repurposing of yunnan baiyao as an alternative therapy for minor recurrent
aphthous stomatitis. [2012]
Psychogenic nonepileptic seizures: a treatment review. What have we learned since
the beginning of the millennium? [2012]
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With
Type 2 Diabetes and Coronary Artery Disease. [2012]
Randomized controlled trial of interventions for young people at ultra-high risk
of psychosis: twelve-month outcome. [2012]
Current position of phenobarbital in epilepsy and its future. [2012]
The DRD4 Exon III VNTR, Bupropion, and Associations With Prospective Abstinence. [2012]
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results
of two randomized, double-blind, parallel-sequential trials. [2012]
Assessment of the effects of a stannous fluoride dentifrice on gingivitis in a
two-month positive-controlled clinical study. [2012]
The effect of zinc acetate and magnolia bark extract added to chewing gum on
volatile sulfur-containing compounds in the oral cavity. [2012]
Effects of continuous positive airway pressure on neurocognitive function in
obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy
Study (APPLES). [2012]
|
